These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunotherapy for Lung Cancer. Reinmuth N; Reck M Oncol Res Treat; 2016; 39(6):360-8. PubMed ID: 27259861 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of Brain Cancer. Roth P; Preusser M; Weller M Oncol Res Treat; 2016; 39(6):326-34. PubMed ID: 27260656 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of Melanoma. Bender C; Hassel JC; Enk A Oncol Res Treat; 2016; 39(6):369-76. PubMed ID: 27259558 [TBL] [Abstract][Full Text] [Related]
6. Advances in Cancer Therapy: Immunotherapies. Marmé D Oncol Res Treat; 2016; 39(6):324-5. PubMed ID: 27260772 [No Abstract] [Full Text] [Related]
7. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy. McArthur HL; Page DB Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644 [TBL] [Abstract][Full Text] [Related]
8. Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium. Curigliano G; Criscitiello C; Esposito A; Fumagalli L; Gelao L; Locatelli M; Minchella I; Goldhirsch A Breast; 2013 Aug; 22 Suppl 2():S96-9. PubMed ID: 24074802 [TBL] [Abstract][Full Text] [Related]
9. Towards a therapeutic breast cancer vaccine: the next steps. Emens LA Expert Rev Vaccines; 2005 Dec; 4(6):831-41. PubMed ID: 16372879 [TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Immunology and Immunotherapy: Current Status and Future Perspectives. de la Cruz-Merino L; Chiesa M; Caballero R; Rojo F; Palazón N; Carrasco FH; Sánchez-Margalet V Int Rev Cell Mol Biol; 2017; 331():1-53. PubMed ID: 28325210 [TBL] [Abstract][Full Text] [Related]
11. The clinical development of vaccines for HER2 Costa RLB; Soliman H; Czerniecki BJ Cancer Treat Rev; 2017 Dec; 61():107-115. PubMed ID: 29125981 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutic options on the horizon in breast cancer treatment. van Rooijen JM; Stutvoet TS; Schröder CP; de Vries EG Pharmacol Ther; 2015 Dec; 156():90-101. PubMed ID: 26388292 [TBL] [Abstract][Full Text] [Related]
13. Checkpoint Blockade - a New Treatment Paradigm in Renal Cell Carcinoma. Grünwald V Oncol Res Treat; 2016; 39(6):353-8. PubMed ID: 27259695 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy in breast cancer: An overview of modern checkpoint blockade strategies and vaccines. Sanchez K; Page D; McArthur HL Curr Probl Cancer; 2016; 40(2-4):151-162. PubMed ID: 27855963 [TBL] [Abstract][Full Text] [Related]
15. HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development. Arab A; Yazdian-Robati R; Behravan J Arch Immunol Ther Exp (Warsz); 2020 Jan; 68(1):2. PubMed ID: 31915932 [TBL] [Abstract][Full Text] [Related]
16. Current immunotherapeutic strategies in breast cancer. Carson WE; Liang MI Surg Oncol Clin N Am; 2007 Oct; 16(4):841-60, ix. PubMed ID: 18022548 [TBL] [Abstract][Full Text] [Related]
17. Immune approaches to the treatment of breast cancer, around the corner? Criscitiello C; Esposito A; Gelao L; Fumagalli L; Locatelli M; Minchella I; Adamoli L; Goldhirsch A; Curigliano G Breast Cancer Res; 2014 Feb; 16(1):204. PubMed ID: 25774617 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for the treatment of breast cancer. Ernst B; Anderson KS Curr Oncol Rep; 2015 Feb; 17(2):5. PubMed ID: 25677118 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of breast cancer. Wright SE Expert Opin Biol Ther; 2012 Apr; 12(4):479-90. PubMed ID: 22413825 [TBL] [Abstract][Full Text] [Related]
20. Advancing Immunotherapy in Metastatic Breast Cancer. Mansour M; Teo ZL; Luen SJ; Loi S Curr Treat Options Oncol; 2017 Jun; 18(6):35. PubMed ID: 28534250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]